期刊文献+

索法酮在大鼠体内的药动学研究

In vivo pharmacokinetic study on sofalcone in rats
原文传递
导出
摘要 目的研究索法酮在大鼠体内的药动学特点。方法建立大鼠血浆中索法酮的HPLC检测方法,考察大鼠ig给药索法酮24 h内血药浓度,计算药动学参数。结果 ig给予100 mg/kg索法酮,Cmax为13.0 mg/kg,AUC为34.7 mg/L。结论索法酮在大鼠体内吸收特点非常明确,可为索法酮制剂研究提供依据。 Objective To study in vivo pharmacokinetic characteristics of sofalcone in rats.Methods HPLC method was established to determine the sofalcone in rat's plasma,and investigate the blood concentration after ig administration of sofalcone to rats in 24 h,then pharmacokinetic parameters were calculated.Results Sofalcone raw materials were given by ig administration of 100 mg/kg,then the Cmax was 13.0 mg/kg,and the AUC was 34.7 mg/L.Conclusion The absorption characteristic of sofalcone in rats is clear,which provides the basis for the study on the preparation method of sofalcone.
出处 《现代药物与临床》 CAS 2013年第5期697-699,共3页 Drugs & Clinic
基金 国家重大新药创制专项(2011ZX09401-009) 天津市科技支撑计划重点项目(10ZCKFSH01300)
关键词 索法酮 药动学 高效液相色谱 sofalcone pharmacokinetic HPLC
  • 相关文献

参考文献4

  • 1陆涛,余永强,曹富.抗胃溃疡药索法酮的合成[J].中国现代应用药学,2004,21(5):375-376. 被引量:5
  • 2Hirasawa T, Shojit, Hoshino E, et al. Clinical study of effect of SU-88 on gastric ulcer combination of treatment [J]. Jp Pharmacol Therap, 1982, 10(5): 245-267.
  • 3Yoshiyama H, Nakamura H, Okamoto T, et al. A novel in vitro effect of the mucosal protective agent sofalcone- inhibition of chemotactic motility in Helicobacter pylori [J]. Aliment Pharmacol Ther, 2000 14 (Suppl 1): 230- 236.
  • 4Sang B H, Moon S J, Hee J L, et al. Simultaneous characterization of sofalcone and its metabolite in human plasma by liquid chromatography-tandem mass spectrometry [J]. BullKorean Chem. Soe, 2005, 26(5): 729-734.

二级参考文献4

  • 1Yoshiyama H, Nakamura H, Okamoto T, et al. A novel in vitro effect of the mucosal protective agent sofalcone--inhibition of chemotactic motility in Helicobacter pylori[J]. Aliment. Pharmacol. Ther. 2000, Suppl 1:230.
  • 2Matsuo Y, Seki A, Yakabi K, et al. Effect of 2'-carboxymethoxy4, 4'-bis(3-methyl-2-butenyl-oxy) chalcone ( SU-88 ) on gastric local blood flow[J]. Arzneimittel-Forsch 1983, 33:242.
  • 3Kyogoku K, Hatayama K, Yokomori S, et al. 2-( carboxymethoxy) -chalcones[ P]. US. Patent 4,085,135, 1978-04-18; CA87:167734a.
  • 4Kyogoku K, Hatayama K, Yokomori S, et al. Anti-ulcer effect of isoprenyl f;avonoids. Ⅱ. Synthesis and anti-ulcer activity of new chalcones related to sophoradin[ J]. Chem Pharm Bull, 1979, 27(12): 2943.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部